Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001829126-23-007543
Filing Date
2023-11-17
Accepted
2023-11-17 16:03:19
Documents
1
Period of Report
2023-11-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A titanpharma_pre14a.htm PRE 14A 135688
  Complete submission text file 0001829126-23-007543.txt   136746
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-13341 | Film No.: 231418531
SIC: 2836 Biological Products, (No Diagnostic Substances)